These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11511144)

  • 1. The treatment of lupus nephritis: revisiting Galen.
    Lewis EJ
    Ann Intern Med; 2001 Aug; 135(4):296-8. PubMed ID: 11511144
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term outcome in lupus nephritis.
    Spiera RF; Homel P; Spiera H
    Ann Intern Med; 2002 Sep; 137(6):545-6; author reply 545-6. PubMed ID: 12230360
    [No Abstract]   [Full Text] [Related]  

  • 3. Summaries for patients. Kidney disease in patients with lupus who are treated with potent drugs that suppress the immune system.
    Ann Intern Med; 2001 Aug; 135(4):S-29. PubMed ID: 11529202
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of proliferative lupus nephritis: a changing landscape.
    Adu D
    Kidney Int; 2006 Aug; 70(4):616-8. PubMed ID: 16900218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
    Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of nephritis in systemic lupus erythematodes].
    Ligtenberg G; Derksen RH; Berden JH
    Ned Tijdschr Geneeskd; 1996 Sep; 140(39):1941-4. PubMed ID: 8927179
    [No Abstract]   [Full Text] [Related]  

  • 7. Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial.
    Chen W; Tang X; Liu Q; Chen W; Fu P; Liu F; Liao Y; Yang Z; Zhang J; Chen J; Lou T; Fu J; Kong Y; Liu Z; Fan A; Rao S; Li Z; Yu X
    Am J Kidney Dis; 2011 Feb; 57(2):235-44. PubMed ID: 21177013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.
    Burchardi C; Schlöndorff D
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):314-5. PubMed ID: 16932452
    [No Abstract]   [Full Text] [Related]  

  • 9. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.
    Gourley MF; Austin HA; Scott D; Yarboro CH; Vaughan EM; Muir J; Boumpas DT; Klippel JH; Balow JE; Steinberg AD
    Ann Intern Med; 1996 Oct; 125(7):549-57. PubMed ID: 8815753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.
    Illei GG; Austin HA; Crane M; Collins L; Gourley MF; Yarboro CH; Vaughan EM; Kuroiwa T; Danning CL; Steinberg AD; Klippel JH; Balow JE; Boumpas DT
    Ann Intern Med; 2001 Aug; 135(4):248-57. PubMed ID: 11511139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
    Ruiz-Irastorza G; Ugarte A; Saint-Pastou Terrier C; Lazaro E; Iza A; Couzi L; Saenz R; Richez C; Porta S; Blanco P
    Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission from lupus nephritis resistant to cyclophosphamide after additional treatment with cyclosporin A.
    Ferrario L; Bellone M; Bozzolo E; Baldissera E; Sabbadini MG
    Rheumatology (Oxford); 2000 Feb; 39(2):218-220. PubMed ID: 10725082
    [No Abstract]   [Full Text] [Related]  

  • 14. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
    Liu Z; Zhang H; Liu Z; Xing C; Fu P; Ni Z; Chen J; Lin H; Liu F; He Y; He Y; Miao L; Chen N; Li Y; Gu Y; Shi W; Hu W; Liu Z; Bao H; Zeng C; Zhou M
    Ann Intern Med; 2015 Jan; 162(1):18-26. PubMed ID: 25383558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil for lupus nephritis.
    McCune WJ
    N Engl J Med; 2005 Nov; 353(21):2282-4. PubMed ID: 16306526
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
    Fujinaga S; Kaneko K; Ohtomo Y; Murakami H; Takada M; Akashi S; Hira M; Yamashiro Y
    Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
    N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis.
    Ann Intern Med; 2015 Jan; 162(1):I24. PubMed ID: 25383607
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interdisciplinary consensus to management of lupus nephritis in Germany].
    de Groot K
    Z Rheumatol; 2007 Dec; 66(8):724, 726. PubMed ID: 17965864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.
    Karassa FB; Isenberg DA
    N Engl J Med; 2001 Feb; 344(5):382-3. PubMed ID: 11195799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.